In a significant step for the Pharma business in Iraq, the Dlbeen Group introduced “Potafast,” a Swiss painkiller product, at a prestigious event held in Erbil, Kurdistan. The event gathered renowned doctors and healthcare professionals from the field of pharma to witness the unveiling of this innovative pain relief solution. Potafast is poised to make waves in the world of pain management with its Swiss precision and advanced formulation. This painkiller is designed to provide effective relief for a wide range of pain, promising both safety and efficacy for patients in need. The event in Erbil proved the Dlbeen Group’s commitment to improving healthcare through innovation and collaboration in Iraq and the Kurdistan region.